Doctor profile · Federal record
Dr. GEOFFREY CHUPP, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · NEW HAVEN, CT
- NPI 1811970577
- Accepts Medicare
- MIPS 71.7 / 100 · 2023
- 36 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
789 HOWARD AVE, FITKIN BUILDING
NEW HAVEN, CT 065191304
(203) 785-4198
fax (203) 785-3826 - Mailing address
-
PO BOX 9805, 300 GEORGE ST 6TH FLOOR
NEW HAVEN, CT 065360805
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- June 25, 2008
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Connecticut #036156
- Medicaid
- CT #001361568
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811970577. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
176
Distinct HCPCS
6
Medicare allowed
$18,262
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 80 | 56 | $103 | |
99291 |
Critical care, first 30-74 minutes | 34 | 19 | $225 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 19 | 17 | $103 | |
94010 |
Test to measure expiratory airflow and volume | 15 | 12 | $9 | |
94727 |
Test to determine lung volumes using gas dilution or washout | 14 | 12 | $12 | |
94729 |
Test to examine how well the lungs exchange gases | 14 | 12 | $9 |
In context: peer comparison
Among 25 peers in this city , average services per provider: 57. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$91,863
Transactions
55
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $33,294.27 | |
| GENZYME CORPORATION | 10 | $21,666.25 | |
| AstraZeneca Pharmaceuticals LP | 15 | $10,832.69 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $9,246.17 | |
| AstraZeneca AB | 3 | $5,772.75 | |
| Genentech USA, Inc. | 4 | $5,550.65 | |
| Shionogi Inc | 2 | $5,500.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
944
Patients
227
Total drug cost
$1,113,778
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 169 | 31 | $138,483 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 155 | 58 | $7,257 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 102 | 25 | $60,756 |
| Montelukast Sodium | Generic | 78 | 28 | $1,664 |
| Nucala (Mepolizumab) | Brand | 70 | 0 | $497,568 |
| Azithromycin | Generic | 57 | 30 | $388 |
| Prednisone | Generic | 54 | 32 | $402 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 51 | 11 | $34,923 |
| Arnuity Ellipta (Fluticasone Furoate) | Brand | 32 | 0 | $11,827 |
| Dupixent Pen (Dupilumab) | Brand | 32 | 0 | $123,152 |